Dr. Jorg Taubel will be attending the EPI | Lifestyle Scientific Sessions 2024. Taking place from 18th to 21st March in Chicago, Illinois, this event is a cornerstone for professionals in the field of epidemiology, prevention, and lifestyle medicine, with a particular focus on cardiometabolic health.
Dr. Taubel's presence at the conference promises to enrich the discussions and debates surrounding epidemiological cardiovascular issues and the impact of lifestyle trends. We anticipate engaging sessions that delve deep into understanding and addressing the intersection of lifestyle factors and cardiovascular health.
Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director
July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
